Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-15-019554
Filing Date
2015-05-14
Accepted
2015-05-14 11:54:52
Documents
1
Period of Report
2015-05-12

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 17499
  Complete submission text file 0001140361-15-019554.txt   18832
Mailing Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879
Business Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Issuer) CIK: 0001367644 (see all company filings)

EIN.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2273 RESEARCH BLVD., SUITE 400 ROCKVILLE MD 20850
Business Address
Harsanyi Zsolt (Reporting) CIK: 0001380184 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33137 | Film No.: 15861327